DMW – Klinischer Fortschritt, Table of Contents Dtsch Med Wochenschr 2012; 137(49): 2589DOI: 10.1055/s-0032-1327299 Korrespondenz | Correspondence Leserbrief © Georg Thieme Verlag KG Stuttgart · New YorkChronisch-obstruktive Lungenerkrankung (COPD)Chronic obstructive pulmonary disease (COPD)Authors Author Affiliations P. Pommer 1 Klinik am Kofel, Gesundheitszentrum Oberammergau Recommend Article Abstract Buy Article(opens in new window) Full Text References Literatur 1 Koczulla AR, Greulich T, Beutel B et al. Chronisch obstruktive Lungenerkrankung (COPD). Dtsch Med Wochenschr 2012; 137: 1185-1187 2 Protocol. http://www.nejm.org/doi/suppl/10.1056/NEJMoa1008378/suppl_file/nejmoa1008378_protocol.pdf 3 Singh S, Loke YK, Enright PL, Furberg CD. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2011; 342: d3215 doi:101136/bmj.d3215 4 Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. A systematic review and meta-analysis. JAMA 2008; 300: 1439-1450 5 Tashkin DP, Celli B, Senn S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-1554
